Atlas Trials

Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine

Clinical trial NCT00401973 · COMPLETED

Trial details

NCT number
NCT00401973
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective Disorders
Start date
2006-11-01
Primary completion
2008-09-01
Enrollment
199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.